Designs and manufactures spacecraft platforms and constellations. Provides end-to-end solutions covering the entire spacecraft lifecycle. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
This company is not turning a profit, so the market is pricing its sales instead: 2.7× for every dollar of annual revenue.
Against companies in its own sector, it looks cheaper than 26% of them.
Analysts' average target sits 131% above today's price.
Executives buying with their own money is usually read as confidence in the company’s future.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
There is growth, but not at top-of-the-class tempo.
Clearly below the class average.
Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.
Business Quality: Profit power and business quality trail similar companies in the sector.
Over the last 2 years, sales grew about 27% a year on average.
Sales run at $386.2M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 19 buys and 8 sells. Management buying with its own money is usually read as a good sign.
A loss of $84.5M against $386.2M in annual sales.
This stock swings about 4.4 times as much as the market average. Big rallies — and big drops — can both happen fast.
At the current pace of spending, the cash lasts about 1.9 years. After that, the company needs to find new money.
On our five-subject report card, YSS sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: YSS is a high-risk stock — not yet profitable, and its future rides on its product catching on.
Analysts’ average target sits above today’s price, yet the valuation grade (26/100) says the stock isn’t cheap.
Not covered, because the filings we hold do not carry it: the growth trend, earnings execution, the revenue breakdown, the price history.